Sponsor:
Miltenyi Biomedicine GmbH
Code:
NCT04792489
Conditions
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Relapsed Diffuse Large B Cell Lymphoma
High Grade B-cell Lymphoma (HGBCL)
Primary Mediastinal B-cell Lymphoma (PMBCL)
Transformed Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
zamtocabtagene autoleucel (MB-CART2019.1)
Cyclophosphamide
Fludarabine
Bendamustine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations